Automated Immunoassay Analyzers Market Share

North America Market Analysis

North America is likely to retain the leading position in the automated immunoassay analyzers market, accounting for the largest share of 38% during the forecast period owing to rising cases of chronic diseases as well as the presence of key players on its grounds. In addition to this, the overall diffusion of technologically advanced health tools and a rising demand for accurate diagnosis can boost market growth going ahead.

The U.S. is anticipated to lead the market through 2036. A combination of high healthcare expenditure, along with a focus on enhancing diagnostic accuracy, drives the automated immunoassay analyzers market in the U.S.  Major companies operating in the U.S. advance the market due to continuous innovation and new product launches. In March 2023, bioMérieux invested in Proxim Diagnostics to develop a fully automated immunodiagnostic tool called the Profile System. This reflects the continued efforts toward strengthening diagnostics with efficiency and accuracy, crucial in managing the rising tide of chronic infectious diseases.

In Canada, government initiatives to advance access to healthcare and diagnostic capabilities promote market growth. In its 2023 report, Health Canada indicated that millions are invested in modernizing diagnostic equipment in public hospitals to increase early diagnosis and effective treatment of diseases. This could be a commitment to the betterment of healthcare and is thus likely to drive the use of automated immunoassay analyzers across the country.

Asia Pacific Market Analysis

Asia Pacific automated immunoassay analyzers market is likely to witness rapid expansion during the forecast period due to the rising burden of chronic diseases and improving healthcare expenditure in the region. Other factors such as a huge population base and growing awareness associated with the early detection of diseases are expected to boost market growth. India, China, and Japan are some of the largest revenue-generating countries in the region, each presenting distinctive growth opportunities.

The automated immunoassay analyzers market is expanding rapidly in India, owing to governmental initiatives taken to improve the healthcare infrastructure and the rising prevalence of various chronic diseases. The National Health Mission by the Indian government has been one of the focused initiatives to promote the adoption of advanced diagnostic tools across rural and urban healthcare centers. 

The automated immunoassay analyzers market growth in China is fueled by an increased focus on the modernization of healthcare and an unprecedented demand for competent diagnostic solutions within the country. The government has brought into action, various healthcare reforms to facilitate access to superior diagnostic tools. In May 2023, Mindray launched a new chemiluminescent immunoassay analyzer, extending its portfolio to meet the increasing demand for high-output testing in hospitals and diagnostic laboratories.